Translucence Biosystems

Executive Summary

Translucence Biosystems is a biotechnology company based in Irvine, CA, specializing in an integrated platform for 3D tissue analysis. Founded in 2019, the company combines proprietary tissue clearing methods, light sheet microscopy hardware modifications, and AI-powered data processing to enable whole-organ and whole-brain imaging. Its offerings include reagent kits, hardware upgrades, and full-service analytical pipelines aimed at neuroscience and drug discovery research. By addressing the challenge of imaging complex, opaque biological structures at scale, Translucence aims to accelerate discoveries in organ systems and diseases. The company operates in the rapidly growing 3D imaging and tissue clearing market, with potential applications in neurology, oncology, and drug development. Though still private and early-stage, its technology could become a key enabler for researchers seeking to visualize entire organs without physical sectioning.

Upcoming Catalysts (preview)

• Q3 2026Series A Funding Announcement70% success
• Q4 2026Strategic Partnership with Major Pharma for Drug Discovery50% success
• Q2 2026Launch of New Whole-Brain Imaging Service75% success